세계의 진단용 웨어러블 의료기기 시장(2024-2028년)

The diagnostic wearable medical devices market is forecasted to grow by USD 8.76 bn during 2023-2028, accelerating at a CAGR of 15.69% during the forecast period. The report on the diagnostic wearable medical devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, growing demand for early diagnosis and preventive medicine, and increased need for cost-effective diagnosis.

Technavio's diagnostic wearable medical devices market is segmented as below:

By Device

• Vital signs monitors
• Sleep and activity monitors
• Fetal and obstetric monitoring devices
• Neuromonitoring devices
• ECG monitors

By Application

• Home healthcare
• Sports and fitness
• Remote patient monitoring

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing penetration of diagnostic wearable medical devices in medical sector as one of the prime reasons driving the diagnostic wearable medical devices market growth during the next few years. Also, rising focus on mental health monitoring and miniaturization of diagnostic wearable medical devices will lead to sizable demand in the market.

The report on the diagnostic wearable medical devices market covers the following areas:

• Diagnostic wearable medical devices market sizing
• Diagnostic wearable medical devices market forecast
• Diagnostic wearable medical devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diagnostic wearable medical devices market vendors that include Activinsights Ltd., AliveCor Inc., Alphabet Inc., Apple Inc., Boyd Corp., BTS Bioengineering Corp., Cleveland Medical Devices Inc., Dragerwerk AG and Co. KGaA, Johari Digital India Ltd., Koninklijke Philips N.V., Medtronic Plc, Meril Life Sciences Pvt. Ltd., Molex LLC, Murata Vios, Inc., OMRON Corp., ResMed Inc., Sanmina Corp., VitalConnect Inc., Wellue Health, and Intelesens Ltd.. Also, the diagnostic wearable medical devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global diagnostic wearable medical devices market 2018 - 2022
• 4.2 Device Segment Analysis 2018 - 2022
• 4.3 Application Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Device

• 6.1 Market segments
• 6.2 Comparison by Device
• 6.3 Vital signs monitors - Market size and forecast 2023-2028
• 6.4 Sleep and activity monitors - Market size and forecast 2023-2028
• 6.5 Fetal and obstetric monitoring devices - Market size and forecast 2023-2028
• 6.6 Neuromonitoring devices - Market size and forecast 2023-2028
• 6.7 ECG monitors - Market size and forecast 2023-2028
• 6.8 Market opportunity by Device

7 Market Segmentation by Application

• 7.1 Market segments
• 7.2 Comparison by Application
• 7.3 Home healthcare - Market size and forecast 2023-2028
• 7.4 Sports and fitness - Market size and forecast 2023-2028
• 7.5 Remote patient monitoring - Market size and forecast 2023-2028
• 7.6 Market opportunity by Application

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 China - Market size and forecast 2023-2028
• 9.9 UK - Market size and forecast 2023-2028
• 9.10 Germany - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Activinsights Ltd.
• 12.4 AliveCor Inc.
• 12.5 Alphabet Inc.
• 12.6 BTS Bioengineering Corp.
• 12.7 Cleveland Medical Devices Inc.
• 12.8 Dragerwerk AG and Co. KGaA
• 12.9 Intelesens Ltd.
• 12.10 Koninklijke Philips N.V.
• 12.11 Medtronic Plc
• 12.12 Molex LLC
• 12.13 Murata Vios, Inc.
• 12.14 OMRON Corp.
• 12.15 ResMed Inc.
• 12.16 VitalConnect Inc.
• 12.17 Wellue Health

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations